Bruno Stieger

Active 1981–2024

109
Papers
23,173
Citations
89
h-index
109
i10-index

Citations

Citations per year for Bruno Stieger1981: 1 citations1983: 1 citations1984: 1 citations1985: 2 citations1986: 2 citations1987: 1 citations1988: 6 citations1989: 16 citations1990: 23 citations1991: 29 citations1992: 24 citations1993: 46 citations1994: 46 citations1995: 34 citations1996: 37 citations1997: 80 citations1998: 109 citations1999: 206 citations2000: 245 citations2001: 308 citations2002: 345 citations2003: 334 citations2004: 294 citations2005: 232 citations2006: 290 citations2007: 193 citations2008: 249 citations2009: 255 citations2010: 308 citations2011: 186 citations2012: 167 citations2013: 273 citations2014: 197 citations2015: 161 citations2016: 196 citations2017: 178 citations2018: 131 citations2019: 530 citations2020: 396 citations2021: 421 citations2022: 319 citations2023: 204 citations2024: 352 citations2025: 123 citations2026: 9 citations1982: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,671 citing papers, 26.5% of this breakdownGermany: 611 citing papers, 9.7% of this breakdownChina: 507 citing papers, 8% of this breakdownJapan: 357 citing papers, 5.7% of this breakdownSwitzerland: 349 citing papers, 5.5% of this breakdownUnited Kingdom: 320 citing papers, 5.1% of this breakdownNetherlands: 317 citing papers, 5% of this breakdownFrance: 234 citing papers, 3.7% of this breakdownCanada: 164 citing papers, 2.6% of this breakdownSweden: 150 citing papers, 2.4% of this breakdownItaly: 148 citing papers, 2.4% of this breakdownAustria: 119 citing papers, 1.9% of this breakdown
0%26.5%Other 21.5%

Fields

  • Medicine65.5%
  • Biochemistry, Genetics and Molecular Biology17.1%
  • Pharmacology, Toxicology and Pharmaceutics4.9%
  • Engineering3%
  • Neuroscience2%
  • Nursing1.8%
  • Other5.7%

Topics

  • Drug Transport and Resistance Mechanisms16.5%
  • Pharmacological Effects and Toxicity Studies5.1%
  • Liver Disease Diagnosis and Treatment3.8%
  • Pediatric Hepatobiliary Diseases and Treatments3.7%
  • Pharmacogenetics and Drug Metabolism3.3%
  • Liver physiology and pathology2.6%
  • Other65%

Coauthors

All papers

Open in search
  1. Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrew Gibson, Matthias Glanemann, Christopher E. Goldring, Marı́a José Gómez-Lechón, Geny M. M. Groothuis, Lena Gustavsson, Christelle Guyot, David Hallifax, Seddik Hammad, Adam S. Hayward, Dieter Häussinger, Claus Hellerbrand, Philip Hewitt, Stefan Hoehme, Hermann−Georg Holzhütter, J. Brian Houston, Jens Hrach, Kiyomi Ito, Hartmut Jaeschke, Verena Keitel, Jens Kelm, B. Kevin Park, Claus Kordes, Gerd A. Kullak‐Ublick, Edward L. LeCluyse, Peng Lü, Jennifer L. Luebke-Wheeler, Anna Lutz, Daniel J. Maltman, Madlen Matz‐Soja, Patrick D. McMullen, Irmgard Merfort, Simon Messner, Christoph Meyer, Jessica Mwinyi, Dean J. Naisbitt, Andreas K. Nüssler, Peter Olinga, Francesco Pampaloni, Jingbo Pi, Linda Pluta, Stefan Przyborski, Anup Ramachandran, Vera Rogiers, Cliff Rowe, Celine Schelcher, Kathrin Schmich, Michael Schwarz, Bijay Singh, Ernst H. K. Stelzer, Bruno Stieger, Regina Stöber, Yuichi Sugiyama, Ciro Tetta, Wolfgang E. Thasler, Tamara Vanhaecke, Mathieu Vinken, Thomas S. Weiß, A Widera, Courtney G. Woods, Jinghai J. Xu, Kathy Yarborough, Jan G. Hengstler - Archives of Toxicology 2013 cited by 1,275

  2. Structure of human drug transporters OATP1B1 and OATP1B3

    Authors: , , , , , , , - Nature Communications 2023 cited by 89

  3. Physiological and Biochemical Basis of Clinical Liver Function Tests

    Authors: , , , , , , - Annals of Surgery 2012 cited by 340

  4. The SLCO (former SLC21) superfamily of transporters

    Authors: , - Molecular Aspects of Medicine 2013 cited by 382

  5. Bile Salt Transporters

    Authors: , - Annual Review of Physiology 2002 cited by 588

  6. Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Hepatology 2006 cited by 379

  7. Diverse Functional Properties of Wilson Disease ATP7B Variants

    Authors: , , , , , , , , , , , , , - Gastroenterology 2012 cited by 181

  8. Transporters involved in the hepatic uptake of 99mTc-mebrofenin and indocyanine green

    Authors: , , , , , , , , , - Journal of Hepatology 2010 cited by 305

  9. Emerging Transporters of Clinical Importance: An Update From the International Transporter Consortium

    Authors: , , , , , , - Clinical Pharmacology & Therapeutics 2013 cited by 345

  10. Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal

    Authors: , , , , , , , , , - Liver International 2014 cited by 133

  11. In Vitro Methods to Support Transporter Evaluation in Drug Discovery and Development

    Authors: , , , , , , , , - Clinical Pharmacology & Therapeutics 2013 cited by 264

  12. The Role of the Sodium-Taurocholate Cotransporting Polypeptide (NTCP) and of the Bile Salt Export Pump (BSEP) in Physiology and Pathophysiology of Bile Formation

    Authors: - Handbook of experimental pharmacology 2010 cited by 264

  13. Impaired uptake of conjugated bile acids and hepatitis b virus pres1‐binding in na+‐taurocholate cotransporting polypeptide knockout mice

    Authors: , , , , , , , , , , , , - Hepatology 2015 cited by 140

  14. Atp8b1 and Abcb11 Analysis in 62 Children With Normal Gamma-Glutamyl Transferase Progressive Familial Intrahepatic Cholestasis (Pfic): Phenotypic Differences Between Pfic1 and Pfic2 and Natural History

    Authors: , , , , , , , - Hepatology 2010 cited by 287

  15. Mechanisms of pH-gradient driven transport mediated by organic anion polypeptide transporters

    Authors: , , , , , - American Journal of Physiology-Cell Physiology 2009 cited by 190

  16. Membrane lipids and transporter function

    Authors: , , - Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2021 cited by 80

  17. Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver

    Authors: , , , , - Gastroenterology 2000 cited by 583

  18. Differential cellular expression of organic anion transporting peptides OATP1A2 and OATP2B1 in the human retina and brain: implications for carrier-mediated transport of neuropeptides and neurosteriods in the CNS

    Authors: , , , - Pflügers Archiv - European Journal of Physiology 2014 cited by 95

  19. Structure of human NTCP reveals the basis of recognition and sodium-driven transport of bile salts into the liver

    Authors: , , , , , , , , - Cell Research 2022 cited by 49

  20. Severe Bile Salt Export Pump Deficiency: 82 Different ABCB11 Mutations in 109 Families

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2008 cited by 378

  21. Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1

    Authors: , , , , , , , - Genome Medicine 2013 cited by 271

  22. Enterohepatic bile salt transporters in normal physiology and liver disease

    Authors: , , - Gastroenterology 2003 cited by 653

  23. Regulation of Drug Transporter Expression in Human Hepatocytes Exposed to the Proinflammatory Cytokines Tumor Necrosis Factor-α or Interleukin-6

    Authors: , , , - Drug Metabolism and Disposition 2008 cited by 259

  24. Characterization of two splice variants of human organic anion transporting polypeptide 3A1 isolated from human brain

    Authors: , , , , , , , , - American Journal of Physiology-Cell Physiology 2006 cited by 162